Diabetes Prevention in Australia: 10 Years Results and Experience

Clinical trials have demonstrated the efficacy of lifestyle modification for the prevention of type 2 diabetes mellitus but it was achieved at higher cost than can be sustained in routine health services. The first clinical trial to report was the Finnish Diabetes Prevention Study. This paper descri...

Full description

Bibliographic Details
Main Author: James A. Dunbar
Format: Article
Language:English
Published: Korean Diabetes Association 2017-02-01
Series:Diabetes & Metabolism Journal
Subjects:
Online Access:https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-41-160.pdf
id doaj-44bccd6740da4d8da3e780d0d1e29c9a
record_format Article
spelling doaj-44bccd6740da4d8da3e780d0d1e29c9a2020-11-25T00:07:21ZengKorean Diabetes AssociationDiabetes & Metabolism Journal2233-60792233-60872017-02-0141316016710.4093/dmj.2017.41.3.160Diabetes Prevention in Australia: 10 Years Results and ExperienceJames A. DunbarClinical trials have demonstrated the efficacy of lifestyle modification for the prevention of type 2 diabetes mellitus but it was achieved at higher cost than can be sustained in routine health services. The first clinical trial to report was the Finnish Diabetes Prevention Study. This paper describes how Australia worked with Finnish colleagues to adapt the findings of that study to achieve a statewide diabetes prevention program. Small evaluative, effectiveness trials have been conducted in a number of countries to see if the results of the clinical trials can be replicated in routine health services. The Australian evaluative trial, Greater Green Triangle Diabetes Prevention Program is described in detail to demonstrate the ingredients for success in moving a program from one country to another. Few countries have managed to scale up from evaluative trials to statewide or national programs. The Australian experience is described in detail including lessons learned about what reduced the effectiveness, particularly the need for policy makers in government, people from the implementing organisation and researchers to work together from the start of the evaluative trial and throughout the first 5 years of a national program.https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-41-160.pdfClinical trialDiabetes mellitus, type 2DietEvaluation studiesGovernment programsGroup processesLife stylePolicy
collection DOAJ
language English
format Article
sources DOAJ
author James A. Dunbar
spellingShingle James A. Dunbar
Diabetes Prevention in Australia: 10 Years Results and Experience
Diabetes & Metabolism Journal
Clinical trial
Diabetes mellitus, type 2
Diet
Evaluation studies
Government programs
Group processes
Life style
Policy
author_facet James A. Dunbar
author_sort James A. Dunbar
title Diabetes Prevention in Australia: 10 Years Results and Experience
title_short Diabetes Prevention in Australia: 10 Years Results and Experience
title_full Diabetes Prevention in Australia: 10 Years Results and Experience
title_fullStr Diabetes Prevention in Australia: 10 Years Results and Experience
title_full_unstemmed Diabetes Prevention in Australia: 10 Years Results and Experience
title_sort diabetes prevention in australia: 10 years results and experience
publisher Korean Diabetes Association
series Diabetes & Metabolism Journal
issn 2233-6079
2233-6087
publishDate 2017-02-01
description Clinical trials have demonstrated the efficacy of lifestyle modification for the prevention of type 2 diabetes mellitus but it was achieved at higher cost than can be sustained in routine health services. The first clinical trial to report was the Finnish Diabetes Prevention Study. This paper describes how Australia worked with Finnish colleagues to adapt the findings of that study to achieve a statewide diabetes prevention program. Small evaluative, effectiveness trials have been conducted in a number of countries to see if the results of the clinical trials can be replicated in routine health services. The Australian evaluative trial, Greater Green Triangle Diabetes Prevention Program is described in detail to demonstrate the ingredients for success in moving a program from one country to another. Few countries have managed to scale up from evaluative trials to statewide or national programs. The Australian experience is described in detail including lessons learned about what reduced the effectiveness, particularly the need for policy makers in government, people from the implementing organisation and researchers to work together from the start of the evaluative trial and throughout the first 5 years of a national program.
topic Clinical trial
Diabetes mellitus, type 2
Diet
Evaluation studies
Government programs
Group processes
Life style
Policy
url https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-41-160.pdf
work_keys_str_mv AT jamesadunbar diabetespreventioninaustralia10yearsresultsandexperience
_version_ 1725418788210343936